The researchers found in mice that accumulation of cholesterol in the liver depletes a powerful antioxidant. The depleted cells are left sensitive to inflammatory factors that cause damage to the liver, they found. The buildup of other forms of fat in the liver, including free fatty acids and triglycerides, were insufficient to spark the events leading to worsening disease.
The findings suggest a key role for the type, as opposed to the amount, of fat in susceptibility to the liver condition known as nonalcoholic steatohepatitis (NASH), said José Fernandez-Checa and Carmen García-Ruiz of Consejo Superior de Investigaciones Científicas (CSIC) in Barcelona.
"To avoid the progression of liver disease, it may be important to eat less and be more conscious of the lipid content of the diet, particularly cholesterol," Fernandez-Checa said. Supplements that boost levels of glutathione--the antioxidant that becomes depleted in animals whose livers accumulate cholesterol--might also be beneficial, he added.
"These data also support a potential therapeutic role of statins in NASH development," he added. Statins are a class of drugs used to lower cholesterol in those at risk of cardiovascular disease.
Characterized by fat accumulation, inflammation, and liver damage, NASH affects 2%–5% percent of Americans. An additional 10%–20% percent of Americans have fat in their liver, but no inflammation or liver damage. Both conditions are becoming more prevalent, possibly due to the rise of obesity.
The accumulation of lipids in the liver cells, mostly in the form of fatty acids and triglycerides, had been considered the first step in the development of fatty liver disease, the researchers said. However, disease progression usually does not occur in the absence of a second hit that promotes oxidative stress, inflammation, cell death, and fibrosis.
In the current study, the researchers examined the connection between fat type and liver disease progression in mice with high levels of particular lipids in the liver as a result of their diet or genetic modifications that left them obese or unable to handle cholesterol properly.
In every case, mice with high levels of cholesterol in their livers became increasingly susceptible to two inflammatory factors known as cytokines, they found. The cholesterol accumulated specifically in the cellular powerhouses known as mitochondria, where it caused a drop in glutathione. Treatments that selectively depleted liver cells of glutathione produced symptoms that mirrored the effects of high liver cholesterol, they reported.
In obese mice, treatment with the cholesterol-lowering drug Atorvastatin prevented the cholesterol increase in mitochondria and restored antioxidant levels, offering protection from liver damage.
The new findings represent some of the first evidence for a role of cholesterol in delivering the "second hit" that leads to full-blown NASH, Fernandez-Checa said.
Earlier studies that found a poor correlation between blood cholesterol levels and fatty liver disease had led to some doubt about cholesterol's role, he added. Cholesterol metabolism is a complicated process, however, such that blood levels might not always reflect the amount of cholesterol in the liver, he said.
Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München
Second research flight into zero gravity
21.10.2016 | Universität Zürich
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences